许华从伏热论治朗格汉斯细胞组织细胞增多症经验
Experience of XU Hua Treating Langerhanscell Histiocytosis from Latent Heat
DOI:10.13192/j.issn.1000-1719.2019.09.011
扫 描 看 全 文
1.广州中医药大学第一临床医学院,广东 广州 510405
2.广州中医药大学第一附属医院,广东 广州 510405
扫 描 看 全 文
陈亚宾, 许华. 许华从伏热论治朗格汉斯细胞组织细胞增多症经验[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.09.011
CHEN Yabin, XU Hua. Experience of XU Hua Treating Langerhanscell Histiocytosis from Latent Heat[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.09.011
陈亚宾, 许华. 许华从伏热论治朗格汉斯细胞组织细胞增多症经验[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.09.011 DOI:
CHEN Yabin, XU Hua. Experience of XU Hua Treating Langerhanscell Histiocytosis from Latent Heat[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.09.011 DOI:
文章介绍许华教授从伏热论治朗格汉斯细胞组织细胞增多症的经验。许教授认为伏热之邪贯穿本病始终,可与风、湿、瘀、毒合邪致病,临床表现多样,病变分布广泛。在治疗上应攻补兼施,以清热凉血、运脾化湿为主,兼以疏风、利湿、化瘀、解毒。主张分方施治,乖张有度。缓解期应定期随诊,一防其缠绵反复,二防其传变他脏。
This paper introduces the experience of professor XU treating langerhanscell histiocytosis from the perspective of latent heat.It is believed that latent heat is throughout the whole process of langerhanscell histiocytosis, accompanied by wind, dampness, blood stasis and toxin.The clinical manifestations are diverse and the lesions are widely distributed.Tonification and purgation in combination of removing heat to cool blood and invigorating spleen foreliminating dampness in the treatment might be recommended, along with dispelling wind, resolving dampness, dispersing blood stasis and detoxification.It is advocated to use different prescriptions moderately.In the remission period, regular follow-up is necessary to prevent recurrence and transmission to other organs.
伏热朗格汉斯细胞组织细胞增多症攻补兼施
latent heatlangerhanscell histiocytosistonification and purgation in combination
Minkov M.Multisystem Langerhans cell histiocytosis in children: current treatment and future directions[J].Paediatr Drugs,2011,13(2): 75-86.
EI Demellawy D,Young JL,de Nanassy J,et al.Langerhans cell histiocytosis: a comprehensive review[J].Pathology,2015,47(4): 294-301.
李丹,李蕙,史宏.儿童朗格罕斯细胞组织细胞增生症34例临床分析[J].中国当代儿科杂志,2017,19(6): 627-631.
Skowronska-Jozwiak E,Sporny S,Szymanska-Duda J,et al.Hypopituitarism and goitre as endocrine manifestation of Langerhans cell histiocytosis(LCH). Case Report[J].Neuro Endocrinol Lett,2016,37(3): 174-178.
许春华,安美玉,陈芬,等.儿童朗格汉斯细胞组织细胞增生症13例临床特征分析[J].中外医疗,2017(35): 33-34.
李晖,熊昊,许琼,等.朗格汉斯细胞组织细胞增生症继发白血病1例[J].中国小儿血液与肿瘤杂志,2016,21(1): 45-46.
陈溪,朱文静,金仙花,等.朗格汉斯细胞组织细胞增生症一例[J].中国麻风皮肤病杂志,2017,33(10): 605-606.
Neel A,Artifoni M,Donadieu J,et al.Langerhans cell histiocytosis in adults[J].Rev Med Interne,2015,36(10): 658-667.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构